Bionet Corp.(TW:1784)
NT$45.00-2.00 (-4.26%)
TW:1784
Bionet Corp. financials statements
NT$45.00
At close:-2.00 (-4.26%)
Bionet Corp. (1784) Ratios
Bionet Corp. Ratios
TW:1784's free cash flow for Q2 2026 was NT$37.19M. For the 2026 fiscal year, TW:1784's free cash flow was decreased by NT$-7.59M and operating cash flow was NT$44.78M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.62 | 5.06 | 3.90 | 3.06 | 2.77 |
| Quick Ratio | 4.31 | 4.86 | 3.73 | 2.87 | 2.45 |
| Cash Ratio | 0.63 | 0.61 | 0.73 | 0.66 | 0.49 |
| Solvency Ratio | 0.14 | 0.17 | 0.19 | 0.16 | 0.14 |
| Operating Cash Flow Ratio | 0.37 | 0.45 | 0.47 | 0.39 | 0.06 |
| Short-Term Operating Cash Flow Coverage | 2.04 | 2.63 | 4.76 | -0.54 | 11.75 |
| Net Current Asset Value | NT$ 1.05B | NT$ 1.24B | NT$ 641.79M | NT$ 234.03M | NT$ 217.50M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.09 | 0.07 | 0.04 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.08 | 0.07 | 0.04 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.42 | 2.36 | 1.98 | 1.70 | 1.63 |
| Debt Service Coverage Ratio | 0.40 | 1.71 | 3.73 | -0.55 | 45.77 |
| Interest Coverage Ratio | -9.64 | 48.78 | 206.57 | 161.67 | 107.73 |
| Debt to Market Cap | 0.84 | 0.02 | 0.01 | -0.09 | 0.00 |
| Interest Debt Per Share | 141.73 | 1.93 | 0.90 | 0.33 | 0.31 |
| Net Debt to EBITDA | -2.92 | -0.98 | -1.32 | -1.28 | -1.33 |
| Profitability Margins | |||||
| Gross Profit Margin | 55.30% | 56.12% | 56.62% | 55.31% | 54.60% |
| EBIT Margin | -1.17% | 8.47% | 9.54% | 7.23% | 4.51% |
| EBITDA Margin | 3.87% | 12.20% | 13.05% | 11.62% | 8.73% |
| Operating Profit Margin | -1.17% | 5.11% | 7.51% | 7.55% | 4.55% |
| Pretax Profit Margin | 1.56% | 8.37% | 9.50% | 7.19% | 4.47% |
| Net Profit Margin | 4.16% | 6.85% | 6.95% | 3.87% | 2.89% |
| Continuous Operations Profit Margin | 0.07% | 5.72% | 7.22% | 5.47% | 3.54% |
| Net Income Per EBT | 266.80% | 81.87% | 73.21% | 53.89% | 64.64% |
| EBT Per EBIT | -133.23% | 163.88% | 126.44% | 95.15% | 98.29% |
| Return on Assets (ROA) | 1.67% | 2.65% | 3.34% | 2.07% | 1.49% |
| Return on Equity (ROE) | 4.04% | 6.27% | 6.60% | 3.51% | 2.43% |
| Return on Capital Employed (ROCE) | -0.54% | 2.26% | 4.19% | 4.64% | 2.73% |
| Return on Invested Capital (ROIC) | -0.02% | 1.50% | 3.12% | 3.95% | 2.15% |
| Return on Tangible Assets | 1.69% | 2.68% | 3.39% | 2.11% | 1.53% |
| Earnings Yield | 59.79% | 2.08% | 2.86% | 1.96% | 1.51% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.08 | 3.95 | 3.92 | 4.08 | 4.72 |
| Payables Turnover | 7.13 | 8.74 | 7.45 | 7.84 | 7.67 |
| Inventory Turnover | 4.39 | 6.59 | 8.81 | 9.38 | 5.27 |
| Fixed Asset Turnover | 1.78 | 2.05 | 2.24 | 1.92 | 1.79 |
| Asset Turnover | 0.40 | 0.39 | 0.48 | 0.53 | 0.52 |
| Working Capital Turnover Ratio | 0.81 | 0.96 | 1.56 | 2.08 | 1.90 |
| Cash Conversion Cycle | 121.34 | 105.95 | 85.55 | 81.81 | 98.99 |
| Days of Sales Outstanding | 89.39 | 92.34 | 93.08 | 89.48 | 77.36 |
| Days of Inventory Outstanding | 83.11 | 55.36 | 41.45 | 38.90 | 69.22 |
| Days of Payables Outstanding | 51.16 | 41.75 | 48.98 | 46.56 | 47.59 |
| Operating Cycle | 172.50 | 147.70 | 134.53 | 128.37 | 146.59 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 178.15 | 3.48 | 3.03 | 2.00 | 0.29 |
| Free Cash Flow Per Share | 19.08 | 1.44 | 2.51 | 1.31 | -0.06 |
| Dividend Paid and CapEx Coverage Ratio | 0.73 | 1.29 | 2.60 | 1.68 | 0.55 |
| Capital Expenditure Coverage Ratio | 1.12 | 1.71 | 5.82 | 2.88 | 0.83 |
| Operating Cash Flow Coverage Ratio | 1.27 | 1.83 | 3.40 | 6.21 | 0.96 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.14 | 0.14 | 0.10 | 0.02 |
| Free Cash Flow Yield | 18.44% | 1.81% | 4.62% | 3.19% | -0.16% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 101.47 | 48.18 | 35.00 | 51.24 | 66.04 |
| Price-to-Sales (P/S) Ratio | 0.07 | 3.29 | 2.43 | 1.98 | 1.91 |
| Price-to-Book (P/B) Ratio | 0.07 | 3.02 | 2.31 | 1.79 | 1.60 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.42 | 55.15 | 21.64 | 31.36 | -630.73 |
| Price-to-Operating Cash Flow Ratio | 0.58 | 22.81 | 17.92 | 20.46 | 126.66 |
| Price-to-Earnings Growth (PEG) Ratio | -2.66 | 7.47 | 0.37 | 1.20 | 0.61 |
| Enterprise Value Multiple | -1.12 | 26.02 | 17.34 | 15.71 | 20.53 |
| Enterprise Value | -53.77M | 3.88B | 2.55B | 1.79B | 1.65B |
| EV to EBITDA | -1.12 | 26.02 | 17.34 | 15.71 | 20.53 |
| EV to Sales | -0.04 | 3.17 | 2.26 | 1.83 | 1.79 |
| EV to Free Cash Flow | -3.39 | 53.15 | 20.11 | 28.99 | -592.24 |
| EV to Operating Cash Flow | -0.36 | 21.98 | 16.66 | 18.91 | 118.93 |
| Tangible Book Value Per Share | 2679.09 | 46.75 | 33.40 | 27.30 | 26.85 |
| Shareholders’ Equity Per Share | 1530.72 | 26.35 | 23.48 | 22.89 | 23.09 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.96 | 0.32 | 0.24 | 0.24 | 0.21 |
| Revenue Per Share | 1488.03 | 24.13 | 22.29 | 20.75 | 19.38 |
| Net Income Per Share | 61.88 | 1.65 | 1.55 | 0.80 | 0.56 |
| Tax Burden | 2.67 | 0.82 | 0.73 | 0.54 | 0.65 |
| Interest Burden | -1.33 | 0.99 | 1.00 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.12 | 0.11 | 0.11 | 0.09 | 0.09 |
| SG&A to Revenue | 0.44 | 0.40 | 0.38 | 0.40 | 0.42 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 |
| Income Quality | 7.68 | 1.73 | 1.43 | 1.34 | 0.34 |
Currency in TWD
